MeVis Medical Solutions AG (FRA:M3V)
Germany
· Delayed Price · Currency is EUR 24.60
0.00 (0.00%)
Last updated: Jun 24, 2025
FRA:M3V Income Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
| 16.64 | 16.97 | 17.34 | 18.76 | 16.21 | 17.13 | Upgrade
| |
Revenue Growth (YoY) | -5.71% | -2.14% | -7.57% | 15.71% | -5.35% | -5.21% | Upgrade
|
Cost of Revenue | 10.71 | 10.54 | 10.34 | 10.17 | 9.29 | 9.18 | Upgrade
|
Gross Profit | 5.93 | 6.43 | 7 | 8.59 | 6.92 | 7.95 | Upgrade
|
Selling, General & Admin | 0.58 | 0.57 | 0.56 | 0.56 | 0.47 | 0.44 | Upgrade
|
Other Operating Expenses | 1.83 | 1.75 | 1.48 | 1.48 | 1.31 | 1.78 | Upgrade
|
Operating Expenses | 2.56 | 2.45 | 2.14 | 2.13 | 1.91 | 2.39 | Upgrade
|
Operating Income | 3.37 | 3.98 | 4.86 | 6.47 | 5.02 | 5.56 | Upgrade
|
Interest Expense | - | - | -0 | - | - | -0 | Upgrade
|
Interest & Investment Income | 0.12 | 0.15 | 0.11 | - | 0.16 | 0.3 | Upgrade
|
Earnings From Equity Investments | - | - | - | 0.18 | - | - | Upgrade
|
Currency Exchange Gain (Loss) | -0.13 | -0.5 | -1.01 | 1.23 | 0.06 | -0.37 | Upgrade
|
Other Non Operating Income (Expenses) | 1.05 | 1.05 | 1.07 | - | - | - | Upgrade
|
EBT Excluding Unusual Items | 4.42 | 4.69 | 5.03 | 7.88 | 5.24 | 5.49 | Upgrade
|
Legal Settlements | - | - | - | - | -0.61 | 0.3 | Upgrade
|
Pretax Income | 4.42 | 4.69 | 5.03 | 7.88 | 4.63 | 5.79 | Upgrade
|
Income Tax Expense | 0.12 | 0.13 | 0.11 | 0.09 | 0.09 | 0.09 | Upgrade
|
Net Income | 4.3 | 4.56 | 4.92 | 7.79 | 4.55 | 5.7 | Upgrade
|
Net Income to Common | 4.3 | 4.56 | 4.92 | 7.79 | 4.55 | 5.7 | Upgrade
|
Net Income Growth | -25.19% | -7.29% | -36.84% | 71.35% | -20.31% | -29.33% | Upgrade
|
Shares Outstanding (Basic) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
Shares Outstanding (Diluted) | 2 | 2 | 2 | 2 | 2 | 2 | Upgrade
|
EPS (Basic) | 2.36 | 2.51 | 2.70 | 4.28 | 2.50 | 3.13 | Upgrade
|
EPS (Diluted) | 2.36 | 2.51 | 2.70 | 4.28 | 2.50 | 3.13 | Upgrade
|
EPS Growth | -25.19% | -7.29% | -36.84% | 71.35% | -20.31% | -29.33% | Upgrade
|
Free Cash Flow | - | 2.84 | 5.77 | 4.72 | 9.08 | 2.79 | Upgrade
|
Free Cash Flow Per Share | - | 1.56 | 3.17 | 2.60 | 4.99 | 1.53 | Upgrade
|
Dividend Per Share | 1.130 | 1.130 | 0.950 | - | - | - | Upgrade
|
Dividend Growth | 18.95% | 18.95% | - | - | - | - | Upgrade
|
Gross Margin | 35.62% | 37.91% | 40.38% | 45.80% | 42.70% | 46.42% | Upgrade
|
Operating Margin | 20.25% | 23.46% | 28.05% | 34.46% | 30.94% | 32.47% | Upgrade
|
Profit Margin | 25.87% | 26.87% | 28.37% | 41.52% | 28.04% | 33.30% | Upgrade
|
Free Cash Flow Margin | - | 16.76% | 33.30% | 25.18% | 56.00% | 16.27% | Upgrade
|
EBITDA | 3.52 | 4.11 | 4.96 | 6.56 | 5.14 | 5.73 | Upgrade
|
EBITDA Margin | 21.16% | 24.25% | 28.60% | 34.96% | 31.71% | 33.45% | Upgrade
|
D&A For EBITDA | 0.15 | 0.13 | 0.1 | 0.09 | 0.13 | 0.17 | Upgrade
|
EBIT | 3.37 | 3.98 | 4.86 | 6.47 | 5.02 | 5.56 | Upgrade
|
EBIT Margin | 20.25% | 23.46% | 28.05% | 34.46% | 30.94% | 32.47% | Upgrade
|
Effective Tax Rate | 2.65% | 2.70% | 2.27% | 1.11% | 1.84% | 1.56% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.